Study of PVS-10200 for the Treatment of Restenosis in Patients With Peripheral Artery Disease (TRIUMPH)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

June 30, 2012

Study Completion Date

October 31, 2012

Conditions

Peripheral Artery Disease

Interventions

BIOLOGICAL

PVS-10200

PVS-10200 is composed of allogeneic human aortic endothelial cells cultured in a gelatin matrix.

Trial Locations (3)

Hopital Europeen Georges Pompidou, Paris

Hopital Bichat, Paris

Centre Hospitalier Universitaire d'Amiens, Amiens